MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced three poster presentations at the 2025 American ...

A total of 561 research papers were presented during the 52nd annual national conference of the Indian Association of ...

Apalutamide decreased risk of death in mCSPC by 23% and 26% compared with enzalutamide and abiraterone acetate, respectively.

PODO Therapeutics, a precision medicine-focused biotechnology company, today announced that it will present its latest research findings at the upcoming American Association for Cancer Research (AACR) ...

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

As part of Earth Week celebrations, the Fay Jones School of Architecture and Design will present lectures and student presentations on Monday and Tuesday in Vol Walker Hall and the Arkansas Union.

Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...

Plus Therapeutics (PSTV) announces the online availability of new data on its lead compound REYOBIQ in an abstract for both an oral ...

Amir Karami, Ph.D., associate professor of Quantitative Methods and Business Analytics in the Collat School of Business, will ...

Doheny Eye Institute, one of the nation's leading vision research institutions, announced that more than 25 of its scientists and clinician-scientists will present their latest research at the ...

On Friday, more than 100 students and trainee researchers from the Texas Tech University Health Sciences Center presented ...

SRINAGAR: The 52nd Annual National Conference of the Indian Association of Preventive and Social Medicine (IAPSMCON 2025) concluded on Sunday here, marking the ...